Competition

  • September 10, 2026

    Thomson Reuters Says DOJ AI Stance Doesn't Back Ross

    Thomson Reuters told the Third Circuit Thursday in defunct legal tech startup Ross Intelligence's interlocutory appeal of a summary judgment ruling that it infringed Westlaw headnotes that a statement by the U.S. Department of Justice flagged by Ross does not support its fair-use defense.

  • September 10, 2026

    Lilly Owes Nektar $1B If It Breached Rezpeg Deal, Jury Told

    Nektar Therapeutics' damages expert told a California federal jury on Thursday that Eli Lilly & Co. could owe the biotechnology company nearly $1 billion if it finds that the pharmaceutical giant breached a license agreement to co-develop Nektar's autoimmune-disease drug Rezpeg.

  • September 10, 2026

    Chinese Vape Co. Wants Price-Fixing MDL Tossed

    Downstream buyers of cannabis vape brand CCell parts are unable to show that an inherently illegal price-fixing and customer-allocation conspiracy existed between the Chinese manufacturer and four distributors, the companies argued in a dismissal bid, telling a California federal court that the multidistrict litigation complaint describes only "ordinary" business dealings.

  • September 10, 2026

    Nielsen Tells 2nd Circ. Court Altered Terms Of Cumulus Order

    Nielsen is headed back to the Second Circuit after a New York federal court changed the terms of a preliminary injunction that the appellate court had already upheld, the company said, requiring Nielsen to not only unbundle its national radio ratings data from its local offerings but also to provide that data on specific terms.

  • September 10, 2026

    Clinical Trial Buyer Says Ex-Owner Breached $100M Deal

    Surge ECN Holdings LLC and ECN Operating LLC have accused the former owner of a clinical trial research network of violating a five-year noncompete and other restrictions tied to a deal worth more than $100 million, alleging he diverted customers, recruited key physicians and used confidential information to build a competing business.

  • September 10, 2026

    Biosimilars Boast Big Savings But Face IP Risks, Report Says

    There are no biosimilar drugs in development for 90% of biologic products set to lose their patent exclusivity by 2034, according to a report released Thursday by the Association for Accessible Medicines, which warned that current patent policy threatens generic-drug development. 

  • September 10, 2026

    Citizens Says SoFi's Poaching 'Decimated' Conn. Mortgage Biz

    Citizens Bank is suing SoFi Bank in Connecticut federal court, alleging its rival poached Citizens Bank employees, stole its trade secrets and "decimated Citizens' mortgage business" in Connecticut. 

  • September 10, 2026

    DOJ Wants To Quash Apple's Look At Fed Phone-Buying

    The U.S. Department of Justice is asking a New Jersey federal court to overrule an order in the government's monopolization case giving Apple a look at how the Pentagon, CIA, U.S. Department of State and other agencies purchase smartphones and smartwatches.

  • September 10, 2026

    Fox Must Produce Carriage Deals In Newsmax Antitrust Suit

    Fox News has to produce its top carriage agreements with cable and streaming providers in Newsmax's antitrust suit accusing Fox of pressuring providers not to carry the rival right-leaning broadcaster, a Florida federal magistrate judge ruled Thursday.

  • September 10, 2026

    EU Beats Challenge To Block €1.6B Booking.com Buy

    A European Union court refused to upend an EU decision blocking Booking.com's €1.63 billion ($1.89 billion) purchase of Swedish flight booking service eTraveli, rejecting Booking's assertions that the European Commission went against its own merger review guidelines.

  • September 10, 2026

    9th Circ. Calls Foul On Judge's NCAA Five-Year Rule Injunction

    The NCAA's five-year eligibility limit may be a commercial rule subject to antitrust scrutiny, but a Nevada federal judge improperly blocked it to let a college baseball player keep playing with little evidence it constrained competition, the Ninth Circuit has said.

  • September 10, 2026

    TPG, Blue Owl, CVC Exploring Deals, And More Rumors

    Private equity firm TPG may be looking to sell Lyric, which could value the healthcare software company at $5 billion; asset manager Blue Owl Capital is exploring the launch of a real estate investment trust; and CVC Capital Partners could sell personal care company Arthea at a $2 billion valuation. 

  • September 10, 2026

    CMA Clears Welltower's $14B Care Home Deal

    The U.K.'s antitrust authority said Thursday that it has cleared Welltower Inc.'s $14 billion acquisition of several care homes in the U.K. after the U.S. real estate investment trust took steps earlier in September to address the regulator's concerns.

  • September 10, 2026

    5th Circ. Upholds NAR Exit From Membership Rules Case

    The Fifth Circuit found a Texas real estate broker failed to show enough evidence in a third amended complaint to bring antitrust claims challenging rules from the National Association of Realtors that mandate trade group membership to gain access to home listings.

  • September 09, 2026

    Nektar CEO Opens Door To Finance Questions In Eli Lilly Trial

    Nektar Therapeutics failed Wednesday to block evidence of its financial condition from entering into a California federal trial over a failed deal to codevelop its drug Rezpeg with Eli Lilly, after its CEO's testimony on cross-examination prompted the judge to allow the evidence for impeachment purposes.

  • September 09, 2026

    Genius Settles With Panda Ahead Of Sports Tech Patent Trial

    Sports technology company Genius Sports Ltd. and Panda Interactive have agreed to settle a patent dispute over technology that allows viewers to see real-time odds and place a bet while watching a sporting event, according to a notice filed in Texas federal court Wednesday.

  • September 09, 2026

    Deckers Denied New Trial On Ugg Boot Design Patent Validity

    A California federal judge denied Deckers Outdoor Corp.'s bid for a new trial over the validity of its design patent for its Ugg Classic Ultra Mini Boot, finding no error in submitting a question of indefiniteness to a jury.

  • September 09, 2026

    Sugar Buyers Want Paul Weiss DQ'd From Price-Fixing MDL

    Hershey, J.M. Smucker and other food makers urged a Minnesota federal judge Tuesday to disqualify Paul Weiss Rifkind Wharton & Garrison LLP from representing Domino Foods in sugar price-fixing multidistrict litigation, arguing the firm is conflicted out because it saw their confidential sugar-purchasing data when it was being considered as plaintiffs' counsel.

  • September 09, 2026

    9th Circ. Deems NCAA's 5-Year Rule Injunction Appeals Moot

    A Ninth Circuit panel on Wednesday tossed the NCAA's appeals of court orders barring it from enforcing its five-year rule to sideline two football players from the 2025 season, finding the cases are moot because the "clock has run out" on the season and the athletes' collegiate careers have wrapped.

  • September 09, 2026

    Humana Says Mylan 'Gamesmanship' Can't Keep Trial Paused

    Humana Inc. asked a Pennsylvania federal judge to restart the countdown to the first trial in the generic-drug price-fixing multidistrict litigation, arguing that Mylan Inc.'s "eleventh-hour delay gambit" of a potential conflict of interest is just the latest in a "carefully choreographed campaign of delaying trial to prevent accountability."

  • September 09, 2026

    Amazon Urges NY Court To Deny E-Book Antitrust Class Cert.

    Amazon on Tuesday objected to a New York federal magistrate judge's recommendation to certify a class of over 30 million customers in a suit accusing it of monopolizing the e-book market, saying the judge disregarded proof that a significant share of the consumers benefited from the challenged practices.

  • September 09, 2026

    Latest $1.5M Turkey Price-Fixing Deal Gets Early OK

    An Illinois federal judge Wednesday gave his initial sign-off to a $1.5 million deal Prestage Farms has inked to resolve certain buyers' claims in sprawling turkey price-fixing antitrust litigation.

  • September 09, 2026

    3rd Circ. Stands By Upholding Lipitor Pay-For-Delay Suit Toss

    The Third Circuit has refused to rethink its decision backing a New Jersey district court's dismissal of an antitrust suit alleging Ranbaxy Laboratories Ltd. conspired to delay a generic version of the cholesterol drug Lipitor.

  • September 09, 2026

    Justices Call For Early Response Over Paramount Merger

    The U.S. Supreme Court is giving California and other state enforcers that are challenging Paramount Skydance Corp.'s planned $110 billion purchase of Warner Bros. until later this month to respond to Iowa and Montana's bid to block the merger challenge.

  • September 09, 2026

    General Mills, Mars Allege Sugar Price-Fixing Scheme

    General Mills, Kellanova, Mars and Little Debbie maker McKee Foods are suing several major U.S. sugar producers in Illinois federal court, accusing them of conspiring to inflate granulated sugar prices for years by secretly sharing sensitive pricing, sales and supply information through an intermediary.

Expert Analysis

  • Series

    Hosting Exchange Students Makes Me A Better Lawyer

    Author Photo

    Opening my home to foreign exchange students makes me a better lawyer not just because prioritizing visiting high schoolers forces me to hone my organization and time management skills but also because sharing the study-abroad experience with newcomers and locals reconnects me to my community, says Alison Lippa at Nicolaides Fink.

  • 2026 Int'l Arbitration Trends: M&A And Securities Disputes

    Author Photo

    Recent developments — such as the high-profile arbitration between ExxonMobil and Chevron, and the U.S. Securities and Exchange Commission's shift on its long-standing opposition to mandatory arbitration clauses in registration statements — highlight key issues to consider when drafting relevant agreements and arbitrating M&A disputes, say attorneys at Cleary.

  • Lessons From Higher Ed's Unexpected Antitrust Claim Trend

    Author Photo

    As higher education institutions face new litigation risk on antitrust grounds, practitioners should familiarize themselves with the types of recent claims that have alleged competitive harm in the higher education space, and expect some combination of other, traditional antitrust tenets to surface as well, says Kendrick Peterson at Baker McKenzie.

  • How A 1947 Tugboat Ruling May Shape Work Product In AI Era

    Author Photo

    Rapid advances in generative artificial intelligence test work-product principles first articulated in the U.S. Supreme Court’s nearly 80-year-old Hickman v. Taylor decision, as courts and ethics bodies confront whether disclosure of attorneys’ AI prompts and outputs would reveal their thought processes, say Larry Silver and Sasha Burton at Langsam Stevens.

  • What's New In ISS' Benchmark Voting Policy Updates For 2026

    Author Photo

    Companies should audit their governance structures and disclosures to prepare for the upcoming proxy season in light of Institutional Shareholder Services' 2026 policy updates, which include tighter guardrails on capital structures and director compensation, and more disclosure-driven assessments of environmental and social shareholder proposals, say attorneys at Fenwick.

  • Navigating Privilege Law Patchwork In Dual-Purpose Comms

    Author Photo

    Three years after the U.S. Supreme Court declined to resolve a circuit split in In re: Grand Jury, federal courts remain split as to when attorney-client privilege applies to dual-purpose legal and business communications, and understanding the fragmented landscape is essential for managing risks, say attorneys at Covington.

  • What Changed For Healthcare Transaction Law In 2025

    Author Photo

    Though much of the legislation introduced last year to expand state scrutiny of healthcare transactions did not pass, investors should pay close attention to the overarching trends, which are likely to continue in this year's legislative sessions, say attorneys at Ropes & Gray.

  • 7 Ways In-House Counsel May Unearth Red Flags In AI M&A

    Author Photo

    In-house counsel and executives conducting M&A due diligence in the artificial intelligence arena can surface hidden liabilities and avoid problems or divestitures by adopting strategies in key areas, including intellectual property provenance and postclose risk management, say attorneys at Reed Smith.

  • Expect State Noncompete Reforms, FTC Scrutiny In 2026

    Author Photo

    Employer noncompete practices are facing intensified federal scrutiny and state reforms heading into 2026, with the Federal Trade Commission pivoting to case-by-case enforcement and states continuing to tighten the rules, especially in the healthcare sector, say attorneys at DLA Piper.

  • Series

    Fly-Fishing Makes Me A Better Lawyer

    Author Photo

    Much like skilled attorneys, the best anglers prize preparation, presentation and patience while respecting their adversaries — both human and trout, says Rob Braverman at Braverman Greenspun.

  • Unpacking The DOJ Meatpacking Probe

    Author Photo

    The recent U.S. Department of Justice meatpacking antitrust investigation is in line with the Trump administration's focus on crimes that affect U.S. consumers, and businesses in other agricultural sectors should be aware of the increased antitrust scrutiny currently aimed at the industry, say attorneys at Norton Rose.

  • 4 Ways GCs Can Manage Growing Service Of Process Volume

    Author Photo

    As automation and arbitration increase the volume of legal filings, in-house counsel must build scalable service of process systems that strengthen corporate governance and manage risk in real time, says Paul Mathews at Corporation Service Co.

  • IP Appellate Decisions Show 4 Shifts In 2025

    Author Photo

    In 2025, intellectual property decisions issued by the Ninth, D.C., and Federal Circuits trended toward tightening doctrinal boundaries, whether to account for technological developments in existing legal regimes, or to refine areas with some ambiguity, says Nate Sabri at Perkins Coie.

  • Series

    The Law Firm Merger Diaries: Forming Measurable Ties

    Author Photo

    Relationship-building should begin as early as possible in a law firm merger, as intentional pathways to bringing people together drive collaboration, positive client response, engagements and growth, says Amie Colby at Troutman.

  • 5 E-Discovery Predictions For 2026 And Beyond

    Author Photo

    2026 will likely be shaped by issues ranging from artificial intelligence regulatory turbulence to potential evidence rule changes, and e-discovery professionals will need to understand how to effectively guide the responsible and defensible adoption of emerging tools, while also ensuring effective safeguards, say attorneys at Littler.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Competition archive.